Microdose Psychedelic Insights

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Click here to get your FREE ticket to Psychedelic Capital today! While the tumultuous year that was 2020 brought numerous unforeseen challenges with it, psychedelic medicine made...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Albert Hofmann, the famous Swiss scientist best known for discovering the psychedelic drug, LSD (lysergic acid diethylamide), would have turned 115 years old today. Endearingly called...

This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission. The revival of psychedelic science and research has produced a fascinating wealth of information about their therapeutic potential. From treatment resistant...

This article By Ali Shana was originally published on Microdose Psychedelic Insights and appears here with permission. Thanks to academic collaboration, legislative change, and biotech-focused drug development, the emerging psychedelic industry is stronger than ever before...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Groundbreaking clinical research has become the bedrock of the modern psychedelic renaissance. One scientist pioneering the way forward in psychedelic and consciousness...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. MagicMed is a Key Player in the Psychedelic Medicine Development Process The current pharmaceutical regulatory process is, to say the least, inherently daunting for most drug...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. CLICK HERE AND GET FREE TICKETS VIA BENZINGA Microdose Psychedelic Insights is pleased to present our first custom event series, leveraging the platform strengths of our...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Mexico may indeed be one step closer to legalizing cannabis nationwide, but the measure falls significantly short in some big ways. Activist Pepe Rivera, part of the Mexican...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Between the incredible progress both cannabis and psychedelics have made in recent years, the options for establishing and maintaining wellness have rapidly expanded. Now, more than...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. As groundbreaking scientific discoveries continue to illustrate the dynamic landscape of psychedelic medicine, many are seeking to invest in the emerging space. There are...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. The innovative team at MagicMed, in pursuit of expanding their novel psychedelic derivative patent library (cleverly dubbed the “Psybrary™”), has formed a...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Microdose is pleased to announce The Mushroom Conference: A Molecular Masterclass is only days away! This exciting virtual event features over 70 world class speakers and...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. Investor interest in the emerging psychedelic medicine sector is on the rise, attracting significant attention from billionaire investors, high profile celebrities, and...

This article was originally published on Microdose Psychedelic Insights and appears here with permission. GET FREE TICKETS TO THURSDAY’S PSYCHEDELIC CAPITAL EVENT HERE The month of October has seen some dramatic developments in the emerging psychedelic capital markets. From ...

This article was originally published on Microdose Psychedelic Insights, and appears here with permission. Recent figures estimate that the abuse of tobacco, alcohol, and drugs within the United States totals to over $1 trillion dollars a year in costs—and counting.1 Between the...